- •Contents
- •Contributors
- •Part I General Principles of Cell Death
- •1 Human Caspases – Apoptosis and Inflammation Signaling Proteases
- •1.1. Apoptosis and limited proteolysis
- •1.2. Caspase evolution
- •2. ACTIVATION MECHANISMS
- •2.2. The activation platforms
- •2.4. Proteolytic maturation
- •3. CASPASE SUBSTRATES
- •4. REGULATION BY NATURAL INHIBITORS
- •REFERENCES
- •2 Inhibitor of Apoptosis Proteins
- •2. CELLULAR FUNCTIONS AND PHENOTYPES OF IAP
- •3. IN VIVO FUNCTIONS OF IAP FAMILY PROTEINS
- •4. SUBCELLULAR LOCATIONS OF IAP
- •8. IAP–IAP INTERACTIONS
- •10. ENDOGENOUS ANTAGONISTS OF IAP
- •11. IAPs AND DISEASE
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2.1. The CD95 (Fas/APO-1) system
- •2.1.1. CD95 and CD95L: discovery of the first direct apoptosis-inducing receptor-ligand system
- •2.1.2. Biochemistry of CD95 apoptosis signaling
- •2.2. The TRAIL (Apo2L) system
- •3.1. The TNF system
- •3.1.1. Biochemistry of TNF signal transduction
- •3.1.2. TNF and TNF blockers in the clinic
- •3.2. The DR3 system
- •4. THE DR6 SYSTEM
- •6. CONCLUDING REMARKS AND OUTLOOK
- •SUGGESTED READINGS
- •4 Mitochondria and Cell Death
- •1. INTRODUCTION
- •2. MITOCHONDRIAL PHYSIOLOGY
- •3. THE MITOCHONDRIAL PATHWAY OF APOPTOSIS
- •9. CONCLUSIONS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •3. INHIBITING APOPTOSIS
- •4. INHIBITING THE INHIBITORS
- •6. THE BCL-2 FAMILY AND CANCER
- •SUGGESTED READINGS
- •6 Endoplasmic Reticulum Stress Response in Cell Death and Cell Survival
- •1. INTRODUCTION
- •2. THE ESR IN YEAST
- •3. THE ESR IN MAMMALS
- •4. THE ESR AND CELL DEATH
- •5. THE ESR IN DEVELOPMENT AND TISSUE HOMEOSTASIS
- •6. THE ESR IN HUMAN DISEASE
- •7. CONCLUSION
- •7 Autophagy – The Liaison between the Lysosomal System and Cell Death
- •1. INTRODUCTION
- •2. AUTOPHAGY
- •2.2. Physiologic functions of autophagy
- •2.3. Autophagy and human pathology
- •3. AUTOPHAGY AND CELL DEATH
- •3.1. Autophagy as anti–cell death mechanism
- •3.2. Autophagy as a cell death mechanism
- •3.3. Molecular players of the autophagy–cell death cross-talk
- •4. AUTOPHAGY, CELLULAR DEATH, AND CANCER
- •5. CONCLUDING REMARKS AND PENDING QUESTIONS
- •SUGGESTED READINGS
- •8 Cell Death in Response to Genotoxic Stress and DNA Damage
- •1. TYPES OF DNA DAMAGE AND REPAIR SYSTEMS
- •2. DNA DAMAGE RESPONSE
- •2.2. Transducers
- •2.3. Effectors
- •4. CHROMATIN MODIFICATIONS
- •5. CELL CYCLE CHECKPOINT REGULATION
- •6. WHEN REPAIR FAILS: SENESCENCE VERSUS APOPTOSIS
- •6.1. DNA damage response and the induction of apoptosis
- •6.2. p53-independent mechanisms of apoptosis
- •6.3. DNA damage response and senescence induction
- •7. DNA DAMAGE FROM OXIDATIVE STRESS
- •SUGGESTED READINGS
- •9 Ceramide and Lipid Mediators in Apoptosis
- •1. INTRODUCTION
- •3.1. Basic cell signaling often involves small molecules
- •3.2. Sphingolipids are cell-signaling molecules
- •3.2.1. Ceramide induces apoptosis
- •3.2.2. Ceramide accumulates during programmed cell death
- •3.2.3. Inhibition of ceramide production alters cell death signaling
- •4.1. Ceramide is generated through SM hydrolysis
- •4.3. aSMase can be activated independently of extracellular receptors to regulate apoptosis
- •4.4. Controversial aspects of the role of aSMase in apoptosis
- •4.5. De novo ceramide synthesis regulates programmed cell death
- •4.6. p53 and Bcl-2–like proteins are connected to de novo ceramide synthesis
- •4.7. The role and regulation of de novo synthesis in ceramide-mediated cell death is poorly understood
- •5. CONCLUDING REMARKS AND FUTURE DIRECTIONS
- •5.1. Who? (Which enzyme?)
- •5.2. What? (Which ceramide?)
- •5.3. Where? (Which compartment?)
- •5.4. When? (At what steps?)
- •5.5. How? (Through what mechanisms?)
- •5.6. What purpose?
- •6. SUMMARY
- •SUGGESTED READINGS
- •1. General Introduction
- •1.1. Cytotoxic lymphocytes and apoptosis
- •2. CYTOTOXIC GRANULES AND GRANULE EXOCYTOSIS
- •2.1. Synthesis and loading of the cytotoxic granule proteins into the secretory granules
- •2.2. The immunological synapse
- •2.3. Secretion of granule proteins
- •2.4. Uptake of proapoptotic proteins into the target cell
- •2.5. Activation of death pathways by granzymes
- •3. GRANULE-BOUND CYTOTOXIC PROTEINS
- •3.1. Perforin
- •3.2. Granulysin
- •3.3. Granzymes
- •3.3.1. GrB-mediated apoptosis
- •3.3.2. GrA-mediated cell death
- •3.3.3. Orphan granzyme-mediated cell death
- •5. CONCLUSIONS
- •REFERENCES
- •Part II Cell Death in Tissues and Organs
- •1.1. Death by trophic factor deprivation
- •1.2. Key molecules regulating neuronal apoptosis during development
- •1.2.1. Roles of caspases and Apaf-1 in neuronal cell death
- •1.2.2. Role of Bcl-2 family members in neuronal cell death
- •1.3. Signal transduction from neurotrophins and neurotrophin receptors
- •1.3.1. Signals for survival
- •1.3.2. Signals for death
- •2.1. Apoptosis in neurodegenerative diseases
- •2.1.4. Amyotrophic lateral sclerosis
- •2.2. Necrotic cell death in neurodegenerative diseases
- •2.2.1. Calpains
- •2.2.2. Cathepsins
- •3. CONCLUSIONS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •5. S-NITROSYLATION OF PARKIN
- •7. POTENTIAL TREATMENT OF EXCESSIVE NMDA-INDUCED Ca2+ INFLUX AND FREE RADICAL GENERATION
- •8. FUTURE THERAPEUTICS: NITROMEMANTINES
- •9. CONCLUSIONS
- •Acknowledgments
- •SUGGESTED READINGS
- •3. MITOCHONDRIAL PERMEABILITY TRANSITION ACTIVATED BY Ca2+ AND OXIDATIVE STRESS
- •4.1. Mitochondrial apoptotic pathways
- •4.2. Bcl-2 family proteins
- •4.3. Caspase-dependent apoptosis
- •4.4. Caspase-independent apoptosis
- •4.5. Calpains in ischemic neural cell death
- •5. SUMMARY
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. HISTORICAL ANTECEDENTS
- •7.1. Activation of p21 waf1/cip1: Targeting extrinsic and intrinsic pathways to death
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •16 Apoptosis and Homeostasis in the Eye
- •1.1. Lens
- •1.2. Retina
- •2. ROLE OF APOPTOSIS IN DISEASES OF THE EYE
- •2.1. Glaucoma
- •2.2. Age-related macular degeneration
- •4. APOPTOSIS AND OCULAR IMMUNE PRIVILEGE
- •5. CONCLUSIONS
- •SUGGESTED READINGS
- •17 Cell Death in the Inner Ear
- •3. THE COCHLEA IS THE HEARING ORGAN
- •3.1. Ototoxic hair cell death
- •3.2. Aminoglycoside-induced hair cell death
- •3.3. Cisplatin-induced hair cell death
- •3.4. Therapeutic strategies to prevent hair cell death
- •3.5. Challenges to studies of hair cell death
- •4. SPIRAL GANGLION NEURON DEATH
- •4.1. Neurotrophic support from sensory hair cells and supporting cells
- •4.2. Afferent activity from hair cells
- •4.3. Molecular manifestations of spiral ganglion neuron death
- •4.4. Therapeutic interventions to prevent SGN death
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •18 Cell Death in the Olfactory System
- •1. Introduction
- •2. Anatomical Aspects
- •3. Life and Death in the Olfactory System
- •3.1. Olfactory epithelium
- •3.2. Olfactory bulb
- •REFERENCES
- •1. Introduction
- •3.1. Beta cell death in the development of T1D
- •3.2. Mechanisms of beta cell death in type 1 diabetes
- •3.2.1. Apoptosis signaling pathways downstream of death receptors and inflammatory cytokines
- •3.2.2. Oxidative stress
- •3.3. Mechanisms of beta cell death in type 2 diabetes
- •3.3.1. Glucolipitoxicity
- •3.3.2. Endoplasmic reticulum stress
- •5. SUMMARY
- •Acknowledgments
- •REFERENCES
- •20 Apoptosis in the Physiology and Diseases of the Respiratory Tract
- •1. APOPTOSIS IN LUNG DEVELOPMENT
- •2. APOPTOSIS IN LUNG PATHOPHYSIOLOGY
- •2.1. Apoptosis in pulmonary inflammation
- •2.2. Apoptosis in acute lung injury
- •2.3. Apoptosis in chronic obstructive pulmonary disease
- •2.4. Apoptosis in interstitial lung diseases
- •2.5. Apoptosis in pulmonary arterial hypertension
- •2.6. Apoptosis in lung cancer
- •SUGGESTED READINGS
- •21 Regulation of Cell Death in the Gastrointestinal Tract
- •1. INTRODUCTION
- •2. ESOPHAGUS
- •3. STOMACH
- •4. SMALL AND LARGE INTESTINE
- •5. LIVER
- •6. PANCREAS
- •7. SUMMARY AND CONCLUDING REMARKS
- •SUGGESTED READINGS
- •22 Apoptosis in the Kidney
- •1. NORMAL KIDNEY STRUCTURE AND FUNCTION
- •3. APOPTOSIS IN ADULT KIDNEY DISEASE
- •4. REGULATION OF APOPTOSIS IN KIDNEY CELLS
- •4.1. Survival factors
- •4.2. Lethal factors
- •4.2.1. TNF superfamily cytokines
- •4.2.2. Other cytokines
- •4.2.3. Glucose
- •4.2.4. Drugs and xenobiotics
- •4.2.5. Ischemia-reperfusion and sepsis
- •5. THERAPEUTIC APPROACHES
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. APOPTOSIS IN THE NORMAL BREAST
- •2.1. Occurrence and role of apoptosis in the developing breast
- •2.2.2. Death ligands and death receptor pathway
- •2.2.4. LIF-STAT3 proapoptotic signaling
- •2.2.5. IGF survival signaling
- •2.2.6. Regulation by adhesion
- •2.2.7. PI3K/AKT pathway: molecular hub for survival signals
- •2.2.8. Downstream regulators of apoptosis: the BCL-2 family members
- •3. APOPTOSIS IN BREAST CANCER
- •3.1. Apoptosis in breast tumorigenesis and cancer progression
- •3.2. Molecular dysregulation of apoptosis in breast cancer
- •3.2.1. Altered expression of death ligands and their receptors in breast cancer
- •3.2.2. Deregulation of prosurvival growth factors and their receptors
- •3.2.3. Alterations in cell adhesion and resistance to anoikis
- •3.2.4. Enhanced activation of the PI3K/AKT pathway in breast cancer
- •3.2.5. p53 inactivation in breast cancer
- •3.2.6. Altered expression of BCL-2 family of proteins in breast cancer
- •5. CONCLUSION
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. DETECTING CELL DEATH IN THE FEMALE GONADS
- •4. APOPTOSIS AND FEMALE REPRODUCTIVE AGING
- •6. CONCLUDING REMARKS
- •REFERENCES
- •25 Apoptotic Signaling in Male Germ Cells
- •1. INTRODUCTION
- •3.1. Murine models
- •3.2. Primate models
- •3.3. Pathways of caspase activation and apoptosis
- •3.4. Apoptotic signaling in male germ cells
- •5. P38 MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) AND NITRIC OXIDE (NO)–MEDIATED INTRINSIC PATHWAY SIGNALING CONSTITUTES A CRITICAL COMPONENT OF APOPTOTIC SIGNALING IN MALE GERM CELLS AFTER HORMONE DEPRIVATION
- •11. CONCLUSIONS AND PERSPECTIVES
- •REFERENCES
- •26 Cell Death in the Cardiovascular System
- •1. INTRODUCTION
- •2. CELL DEATH IN THE VASCULATURE
- •2.1. Apoptosis in the developing blood vessels
- •2.2. Apoptosis in atherosclerosis
- •2.2.1. Vascular smooth muscle cells
- •2.2.2. Macrophages
- •2.2.3. Regulation of apoptosis in atherosclerosis
- •2.2.4. Necrosis and autophagy in atherosclerosis
- •3. CELL DEATH IN THE MYOCARDIUM
- •3.1. Cell death in myocardial infarction
- •3.1.1. Apoptosis in myocardial infarction
- •3.1.2. Necrosis in myocardial infarction
- •3.1.3. Autophagy in myocardial infarction
- •3.2. Cell death in heart failure
- •3.2.1. Apoptosis in heart failure
- •3.2.2. Necrosis in heart failure
- •3.2.3. Autophagy in heart failure
- •4. CONCLUDING REMARKS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •27 Cell Death Regulation in Muscle
- •1. INTRODUCTION TO MUSCLE
- •1.1. Skeletal muscle adaptation to endurance training
- •1.2. Myonuclear domains
- •2. MITOCHONDRIALLY MEDIATED APOPTOSIS IN MUSCLE
- •2.1. Skeletal muscle apoptotic susceptibility
- •4. APOPTOSIS IN MUSCLE DURING AGING AND DISEASE
- •4.1. Aging
- •4.2. Type 2 diabetes mellitus
- •4.3. Cancer cachexia
- •4.4. Chronic heart failure
- •6. CONCLUSION
- •SUGGESTED READINGS
- •28 Cell Death in the Skin
- •1. INTRODUCTION
- •2. CELL DEATH IN SKIN HOMEOSTASIS
- •2.1. Cornification and apoptosis
- •2.2. Death receptors in the skin
- •3. CELL DEATH IN SKIN PATHOLOGY
- •3.1. Sunburn
- •3.2. Skin cancer
- •3.3. Necrolysis
- •3.4. Pemphigus
- •3.5. Eczema
- •3.6. Graft-versus-host disease
- •4. CONCLUDING REMARKS AND PERSPECTIVES
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •29 Apoptosis and Cell Survival in the Immune System
- •2.1. Survival of early hematopoietic progenitors
- •2.2. Sizing of the T-cell population
- •2.2.1. Establishing central tolerance
- •2.2.2. Peripheral tolerance
- •2.2.3. Memory T cells
- •2.3. Control of apoptosis in B-cell development
- •2.3.1. Early B-cell development
- •2.3.2. Deletion of autoreactive B cells
- •2.3.3. Survival and death of activated B cells
- •3. IMPAIRED APOPTOSIS AND LEUKEMOGENESIS
- •4. CONCLUSIONS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •30 Cell Death Regulation in the Hematopoietic System
- •1. INTRODUCTION
- •2. HEMATOPOIETIC STEM CELLS
- •4. ERYTHROPOIESIS
- •5. MEGAKARYOPOIESIS
- •6. GRANULOPOIESIS
- •7. MONOPOIESIS
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •31 Apoptotic Cell Death in Sepsis
- •1. INTRODUCTION
- •2. HOST INFLAMMATORY RESPONSE TO SEPSIS
- •3. CLINICAL OBSERVATIONS OF CELL DEATH IN SEPSIS
- •3.1. Sepsis-induced apoptosis
- •3.2. Necrotic cell death in sepsis
- •4.1. Central role of apoptosis in sepsis mortality: immune effector cells and gut epithelium
- •4.2. Apoptotic pathways in sepsis-induced immune cell death
- •4.3. Investigations implicating the extrinsic apoptotic pathway in sepsis
- •4.4. Investigations implicating the intrinsic apoptotic pathway in sepsis
- •5. THE EFFECT OF APOPTOSIS ON THE IMMUNE SYSTEM
- •5.1. Cellular effects of an increased apoptotic burdens
- •5.2. Network effects of selective loss of immune cell types
- •5.3. Studies of immunomodulation by apoptotic cells in other fields
- •7. CONCLUSION
- •REFERENCES
- •32 Host–Pathogen Interactions
- •1. INTRODUCTION
- •2. FROM THE PATHOGEN PERSPECTIVE
- •2.1. Commensals versus pathogens
- •2.2. Pathogen strategies to infect the host
- •3. HOST DEFENSE
- •3.1. Antimicrobial peptides
- •3.2. PRRs and inflammation
- •3.2.1. TLRs
- •3.2.2. NLRs
- •3.2.3. The Nod signalosome
- •3.2.4. The inflammasome
- •3.3. Cell death
- •3.3.1. Apoptosis and pathogen clearance
- •3.3.2. Pyroptosis
- •3.2.3. Caspase-independent cell death
- •3.2.4. Autophagy and autophagic cell death
- •4. CONCLUSIONS
- •REFERENCES
- •Part III Cell Death in Nonmammalian Organisms
- •1. PHENOTYPE AND ASSAYS OF YEAST APOPTOSIS
- •2.1. Pheromone-induced cell death
- •2.1.1. Colony growth
- •2.1.2. Killer-induced cell death
- •3. EXTERNAL STIMULI THAT INDUCE APOPTOSIS IN YEAST
- •4. THE GENETICS OF YEAST APOPTOSIS
- •5. PROGRAMMED AND ALTRUISTIC AGING
- •SUGGESTED READINGS
- •34 Caenorhabditis elegans and Apoptosis
- •1. Overview
- •2. KILLING
- •3. SPECIFICATION
- •4. EXECUTION
- •4.1. DNA degradation
- •4.2. Mitochondrial elimination
- •4.3. Engulfment
- •5. SUMMARY
- •SUGGESTED READINGS
- •35 Apoptotic Cell Death in Drosophila
- •2. DROSOPHILA CASPASES AND PROXIMAL REGULATORS
- •6. CLOSING COMMENTS
- •SUGGESTED READINGS
- •36 Analysis of Cell Death in Zebrafish
- •1. INTRODUCTION
- •2. WHY USE ZEBRAFISH TO STUDY CELL DEATH?
- •2.2. Molecular techniques to rapidly assess gene function in embryos
- •2.2.1. Studies of gene function using microinjections into early embryos
- •2.2.2. In situ hybridization and immunohistochemistry
- •2.3. Forward genetic screening
- •2.4. Drug and small-molecule screening
- •2.5. Transgenesis
- •2.6. Targeted knockouts
- •3.1. Intrinsic apoptosis
- •3.2. Extrinsic apoptosis
- •3.3. Chk-1 suppressed apoptosis
- •3.4. Anoikis
- •3.5. Autophagy
- •3.6. Necrosis
- •4. DEVELOPMENTAL CELL DEATH IN ZEBRAFISH EMBRYOS
- •5. THE P53 PATHWAY
- •6. PERSPECTIVES AND FUTURE DIRECTIONS
- •SUGGESTED READING
APOPTOSIS
Apoptosis, or cell death, can be pathological, a sign of disease and damage, or physiologic, a process essential for normal health. This pathological dysregulation of cell death can be characterized by either too much loss of essential cells in the heart, brain, and other tissues with little regenerative capacity or too little cell turnover in self-renewing tissues, giving rise to cancer and other maladies. This is a process of fundamental importance for development and normal health, which is altered in many disease conditions. This book, with contributions from experts in the field, provides a timely compilation of reviews of mechanisms of apoptosis. The book is organized into three convenient sections. The first section explores the different processes of cell death and how they relate to each other. The second section focuses on organ-specific apoptosis-related diseases. The third section explores cell death in nonmammalian organisms that have served as popular models for research. This comprehensive text is a must-read for all researchers and scholars interested in apoptosis and cell death.
John C. Reed is Chief Executive Officer of the Sanford-Burnham Medical Research Institute. Dr. Reed is also Professor and Donald Bren Executive Chair at Sanford-Burnham, with adjunct professor appointments at several universities. Dr. Reed and his research team have contributed more than 800 research publications to the literature. Their work is among the most highly cited in all of science worldwide. Dr. Reed is the recipient of numerous awards and honors and has been awarded more than eighty research grants for his work. He is a named inventor for nearly 100 patents and the founder or cofounder of four biotechnology companies. Dr. Reed has served on the editorial boards of numerous journals; as an advisor to numerous public, private, and governmental organizations; and on the boards of directors of several public and private biotechnology companies and life-sciences organizations.
Douglas R. Green is Chair of the Department of Immunology at St. Jude Children’s Research Hospital, where he also holds the Peter Doherty Endowed Chair. Dr. Green came to St. Jude in 2005, prior to which he was Head of the Division of Cellular Immunology at the La Jolla Institute of Allergy and Immunology. Dr. Green serves as an editor for a number of leading journals and is Editor-in-Chief of the journal Oncogene.
APOPTOSIS
PHYSIOLOGY AND PATHOLOGY
Edited by
JOHN C. REED
Sanford-Burnham Medical Research Institute
DOUGLAS R. GREEN
St. Jude Children’s Research Hospital
CAMBRIDGE UNIVERSITY PRESS
Cambridge, New York, Melbourne, Madrid, Cape Town,
Singapore, Sao˜ Paulo, Delhi, Tokyo, Mexico City
Cambridge University Press
32 Avenue of the Americas, New York, NY 10013-2473, USA
www.cambridge.org
Information on this title: www.cambridge.org/9780521886567
C Cambridge University Press 2011
This publication is in copyright. Subject to statutory exception and to the provisions of relevant collective licensing agreements, no reproduction of any part may take place without the written permission of Cambridge University Press.
First published 2011
Printed in the United States of America
A catalog record for this publication is available from the British Library.
Library of Congress Cataloging in Publication data
Apoptosis : physiology and pathology / [edited by] John C. Reed, Douglas R. Green.
p. ; cm.
Includes bibliographical references. ISBN 978-0-521-88656-7 (hardback)
1. Apoptosis. I. Reed, John C., 1958– editor. II. Green, Douglas R., 1955– editor. III. Title.
[DNLM: 1. Apoptosis. 2. Apoptosis – physiology. 3. Cell Death. QU 375] QH671.A6594 2011
611 .01815–dc22 2010045696
ISBN 978-0-521-88656-7 Hardback
Cambridge University Press has no responsibility for the persistence or accuracy of URLs for external or third-party Internet Web sites referred to in this publication and does not guarantee that any content on such Web sites is, or will remain, accurate or appropriate.
Contents
Contributors |
page ix |
I. GENERAL PRINCIPLES OF CELL DEATH
1 Human Caspases – Apoptosis and Inflammation Signaling Proteases . . . . . . . . . . . . . 1
Guy S. Salvesen
2 Inhibitor of Apoptosis Proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Jason B. Garrison, Andreas Krieg, Kate Welsh, Yunfei Wen, and John C. Reed
3 Death Domain–Containing Receptors – Decisions between Suicide and Fire . . . . . 23
Henning Walczak and Chahrazade Kantari
4 Mitochondria and Cell Death . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
Gavin P. McStay and Douglas R. Green
5 The Control of Mitochondrial Apoptosis by the BCL-2 Family . . . . . . . . . . . . . . . . . . 44
Anthony Letai
6 Endoplasmic Reticulum Stress Response in Cell Death and Cell Survival . . . . . . . . . 51
Michael Boyce, Marta M. Lipinski, Ben´edicte´ F. Py, and Junying Yuan
7 Autophagy – The Liaison between the Lysosomal System and Cell Death . . . . . . . . . 63
Hiroshi Koga and Ana Maria Cuervo
8 Cell Death in Response to Genotoxic Stress and DNA Damage . . . . . . . . . . . . . . . . . . 74
Pablo Lopez-Bergami and Ze’ev Ronai
9 Ceramide and Lipid Mediators in Apoptosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
Thomas D. Mullen, Russell W. Jenkins, Lina M. Obeid, and Yusuf A. Hannun
10 Cytotoxic Granules House Potent Proapoptotic Toxins Critical for |
|
Antiviral Responses and Immune Homeostasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
106 |
Katherine Baran, Ilia Voskoboinik, Nigel J. Waterhouse, Vivien R. Sutton,
and Joseph A. Trapani
II. CELL DEATH IN TISSUES AND ORGANS
11 Cell Death in Nervous System Development and Neurological Disease . . . . . . . . . 123
Juying Li and Junying Yuan
12 Role of Programmed Cell Death in Neurodegenerative Disease . . . . . . . . . . . . . . . . 135
Dale E. Bredesen
v
vi |
|
CONTENTS |
13 |
Implications of Nitrosative Stress-Induced Protein Misfolding |
|
|
in Neurodegeneration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
145 |
|
Tomohiro Nakamura and Stuart A. Lipton |
|
14 |
Mitochondrial Mechanisms of Neural Cell Death in Cerebral Ischemia . . . . . . . . . |
153 |
|
Lucian Soane, Brian M. Polster, and Gary Fiskum |
|
15 |
Cell Death in Spinal Cord Injury – An Evolving Taxonomy with |
|
|
Therapeutic Promise . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
164 |
|
Rajiv R. Ratan and Moses V. Chao |
|
16 |
Apoptosis and Homeostasis in the Eye . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
176 |
|
Jerry Y. Niederkorn |
|
17 |
Cell Death in the Inner Ear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
182 |
|
Lisa L. Cunningham and Justin Tan |
|
18 Cell Death in the Olfactory System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194
Pawel Kermer |
|
19 Contribution of Apoptosis to Physiologic Remodeling of the Endocrine |
|
Pancreas and Pathophysiology of Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
201 |
Nika N. Danial |
|
20 Apoptosis in the Physiology and Diseases of the Respiratory Tract . . . . . . . . . . . . . 221
Christian Taube and Martin Schuler
21 Regulation of Cell Death in the Gastrointestinal Tract . . . . . . . . . . . . . . . . . . . . . . . . 231
Maria Eugenia Guicciardi and Gregory J. Gores
22 Apoptosis in the Kidney . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 240
Juan Antonio Moreno, Adrian Mario Ramos, and Alberto Ortiz
23 Physiologic and Pathological Cell Death in the Mammary Gland . . . . . . . . . . . . . . . 250
Armelle Melet and Roya Khosravi-Far
24 Therapeutic Targeting Apoptosis in Female Reproductive Biology . . . . . . . . . . . . . . 273
Kaisa Selesniemi and Jonathan L. Tilly
25 Apoptotic Signaling in Male Germ Cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 283
Amiya P. Sinha Hikim, Yue Jia, Yan-He Lue, Christina Wang, and Ronald S. Swerdloff
26 Cell Death in the Cardiovascular System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 295
Vladimir Kaplinskiy, Martin R. Bennett, and Richard N. Kitsis
27 Cell Death Regulation in Muscle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 313
Ayesha Saleem, Lawrence Kazak, Michael O’Leary, and David A. Hood
28 Cell Death in the Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 323
Saskia Lippens, Esther Hoste, Peter Vandenabeele, and Wim Declercq
29 Apoptosis and Cell Survival in the Immune System . . . . . . . . . . . . . . . . . . . . . . . . . . 333
Delphine Merino´ and Philippe Bouillet
30 Cell Death Regulation in the Hematopoietic System . . . . . . . . . . . . . . . . . . . . . . . . . . 350
Paul A. Ney
31 Apoptotic Cell Death in Sepsis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 363
Pavan Brahmamdam, Jared T. Muenzer, Richard S. Hotchkiss, and Jonathan E. McDunn
32 Host–Pathogen Interactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 372
Maya Saleh
CONTENTS |
vii |
III. CELL DEATH IN NONMAMMALIAN ORGANISMS
33 Programmed Cell Death in the Yeast Saccharomyces cerevisiae . . . . . . . . . . . . . . . . . 389
Valter D. Longo and Cristina Mazzoni
34 Caenorhabditis elegans and Apoptosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 397
Brian L. Harry and Ding Xue
35 Apoptotic Cell Death in Drosophila . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 407
Kathleen Galindo and John M. Abrams
36 Analysis of Cell Death in Zebrafish . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 412
Ujwal J. Pyati and A. Thomas Look
Color plates follow page 226 .
Contributors
John M. Abrams
Genetics and Development Graduate Program
Department of Cell Biology
UT Southwestern Medical Center
Dallas, TX
Katherine Baran
Cancer Immunology Program
Research Division
Peter MacCallum Cancer Centre
Victoria
Australia
Martin R. Bennett
Division of Cardiovascular Medicine
University of Cambridge and Addenbrooke’s Centre for Clinical Investigation
Addenbrooke’s Hospital Cambridge
United Kingdom
Philippe Bouillet
The Walter and Eliza Hall Institute of Medical Research
Melbourne
Australia
Michael Boyce
Department of Cell Biology
Harvard Medical School
Boston, MA
Pavan Brahmamdam
Department of Surgery
Washington University School of Medicine
St. Louis, MO
Dale E. Bredesen
Buck Institute for Research on Aging
University of California – San Francisco
San Francisco, CA
Moses V. Chao
Molecular Neurobiology Program
Skirball Institute of Biomolecular Medicine
New York University Langone School of Medicine
New York, NY
Ana Maria Cuervo
Department of Developmental and Molecular Biology Marion Bessin Liver Research Center
Institute for Aging Research
Albert Einstein College of Medicine Bronx, NY
Lisa L. Cunningham
Section on Sensory Cell Biology National Institute on Deafness and Other
Communication Disorders National Institutes of Health Rockville, MD
Nika N. Danial
Department of Pathology
Harvard Medical School
Department of Cancer Biology
Dana-Farber Cancer Institute
Boston, MA
Wim Declercq
Molecular Signaling and Cell Death Unit Department for Molecular Biomedical Research VIB-Ghent University
Ghent Belgium
Gary Fiskum
Department of Anesthesiology
Shock, Trauma, and Anesthesiology Research Center
University of Maryland School of Medicine
Baltimore, MD
ix
x |
CONTRIBUTORS |
Kathleen Galindo
Department of Cell Biology
UT Southwestern Medical Center
Dallas, TX
Jason B. Garrison
Apoptosis and Cell Death Research Program
Sanford-Burnham Medical Research Institute
La Jolla, CA
Gregory J. Gores
Miles and Shirley Fiterman Center for Digestive Diseases Division of Gastroenterology and Hepatology
Mayo Clinic College of Medicine Rochester, MN
Douglas R. Green
Department of Immunology
St. Jude Children’s Research Hospital
Memphis, TN
Maria Eugenia Guicciardi
Miles and Shirley Fiterman Center for Digestive Diseases Division of Gastroenterology and Hepatology
Mayo Clinic College of Medicine Rochester, MN
Yusuf A. Hannun
Biochemistry and Molecular Biology
Medical University of South Carolina
Charleston, SC
Brian L. Harry
Department of MCD Biology
University of Colorado
Boulder, CO
David A. Hood
School of Kinesiology and Health Science
York University
Toronto, Ontario
Canada
Esther Hoste
Molecular Signaling and Cell Death Unit Department for Molecular Biomedical Research VIB-Ghent University
Ghent Belgium
Richard S. Hotchkiss
Department of Pediatrics
Washington University School of Medicine
St. Louis, MO
Russell W. Jenkins
Biochemistry and Molecular Biology
Medical University of South Carolina
Charleston, SC
Yue Jia
Department of Medicine
Harbor-UCLA Medical Center
Los Angeles Biomedical Research Institute
David Geffen School of Medicine at UCLA
Torrance, CA
Chahrazade Kantari
Tumour Immunology Unit, Department of Medicine
Imperial College London
London
United Kingdom
Vladimir Kaplinskiy
Wilf Family Cardiovascular Research Institute and
Department of Medicine and Cell Biology
Albert Einstein College of Medicine
Bronx, NY
Lawrence Kazak
School of Kinesiology and Health Science
York University
Toronto, Ontario
Canada
Pawel Kermer
Department of Neurology
University Medical Center
DFG Research Center “Molecular Physiology of the
Brain” (CMPB)
Gottingen¨
Germany
Roya Khosravi-Far
Department of Pathology
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, MA
Richard N. Kitsis
Wilf Family Cardiovascular Research Institute
Department of Medicine and Cell Biology
Albert Einstein College of Medicine
Bronx, NY
Hiroshi Koga
Department of Developmental and Molecular Biology Marion Bessin Liver Research Center
Institute for Aging Research
Albert Einstein College of Medicine Bronx, NY
Andreas Krieg
Apoptosis and Cell Death Research Program
Sanford-Burnham Medical Research Institute
La Jolla, CA
Anthony Letai
Department of Medical Oncology
Dana-Farber Cancer Institute
Boston, MA
CONTRIBUTORS |
xi |
Juying Li
Department of Cell Biology
Harvard Medical School
Boston, MA
Marta M. Lipinski
Department of Cell Biology
Harvard Medical School
Boston, MA
Saskia Lippens
Molecular Signaling and Cell Death Unit Department for Molecular Biomedical Research VIB-Ghent University
Ghent Belgium
Stuart A. Lipton
Del E. Web Center for Neuroscience Aging and Stem Cell Research Program
Sanford-Burnham Medical Research Institute La Jolla, CA
Valter D. Longo
Division of Biogerontology
Andrus Gerontology Center
University of Southern California
Los Angeles, CA
A. Thomas Look
Department of Pediatric Oncology
Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA
Pablo Lopez-Bergami
Instituto de Biologia y Medicina Experimental Buenos Aires
Argentina
Yan-He Lue
Department of Medicine
Harbor-UCLA Medical Center
Los Angeles Biomedical Research Institute
David Geffen School of Medicine at UCLA
Torrance, CA
Cristina Mazzoni
Pasteur Institute-Cenci Bolognetti Foundation
Department of Cell and Developmental Biology
University of Rome
Rome
Italy
Jonathan E. McDunn
Department of Anesthesiology Research Unit
Washington University School of Medicine
St. Louis, MO
Gavin P. McStay
Department of Biological Sciences
Columbia University
New York, NY
Armelle Melet
UMR8601
University Paris Descartes
Paris
France
Delphine Merino´
The Walter and Eliza Hall Institute of Medical
Research
Melbourne
Australia
Juan Antonio Moreno
Fundacion Jimenez Diaz
Universidad Autonoma de Madrid
Madrid
Spain
Jared T. Muenzer
Department of Pediatrics
Washington University School of Medicine
St. Louis, MO
Thomas D. Mullen
Biochemistry and Molecular Biology
Medical University of South Carolina
Charleston, SC
Tomohiro Nakamura
Del E. Web Center for Neuroscience Aging and Stem Cell Research
Sanford-Burnham Institute for Medical Research La Jolla, CA
Paul A. Ney
Department of Biochemistry
St. Jude Children’s Research Hospital
Memphis, TN
Jerry Y. Niederkorn
Department of Ophthalmology
UT Southwestern Medical Center
Dallas, TX
Lina M. Obeid
Biochemistry and Molecular Biology
Medical University of South Carolina
Charleston, SC
Michael O’Leary
School of Kinesiology and Health Science
York University
Toronto, Ontario
Canada
Alberto Ortiz
Fundacion Jimenez Diaz
Universidad Autonoma de Madrid
Madrid
Spain
xii |
CONTRIBUTORS |
Brian M. Polster
Department of Anesthesiology
Shock, Trauma, and Anesthesiology Research Center
University of Maryland School of Medicine
Baltimore, MD
Ben´edicte´ F. Py
Department of Cell Biology
Harvard Medical School
Boston, MA
Ujwal J. Pyati
Department of Pediatric Oncology
Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA
Adrian Mario Ramos
Fundacion Jimenez Diaz
Universidad Autonoma de Madrid
Madrid
Spain
Rajiv R. Ratan
Burke-Cornell Medical Research Institute
Weill Medical College of Cornell University
White Plains, NY
John C. Reed
Apoptosis and Cell Death Research Program
Sanford-Burnham Medical Research Institute
La Jolla, CA
Ze’ev Ronai
Signal Transduction Program
Sanford-Burnham Medical Research Institute
La Jolla, CA
Ayesha Saleem
School of Kinesiology and Health Science
York University
Toronto, Ontario
Canada
Maya Saleh
Department of Medicine
McGill University
Montreal, Quebec
Canada
Guy S. Salvesen
Apoptosis and Cell Death Research Program
Sanford-Burnham Medical Research Institute
San Diego, CA
Martin Schuler
Department of Medical Oncology
West German Cancer Center
University Hospital Essen
Essen
Germany
Kaisa Selesniemi
Vincent Center for Reproductive Biology Vincent Obstetrics and Gynecology Service Massachusetts General Hospital
Harvard Medical School Boston, MA
Amiya P. Sinha Hikim
Department of Medicine
Harbor-UCLA Medical Center
Los Angeles Biomedical Research Institute
David Geffen School of Medicine at UCLA
Torrance, CA
Lucian Soane
Department of Anesthesiology
Shock, Trauma, and Anesthesiology Research
Center
University of Maryland School of Medicine
Baltimore, MD
Vivien R. Sutton
Cancer Immunology Program
Research Division
Peter MacCallum Cancer Centre
Victoria
Australia
Ronald S. Swerdloff
Department of Medicine
Harbor-UCLA Medical Center
Los Angeles Biomedical Research Institute
David Geffen School of Medicine at UCLA
Torrance, CA
Justin Tan
The Bionic Ear Institute
East Melbourne
Victoria
Australia
Christian Taube
Department of Medicine
Johannes Gutenberg University Hospital
Mainz
Germany
Jonathan L. Tilly
Vincent Center for Reproductive Biology Vincent Obstetrics and Gynecology Service Massachusetts General Hospital
Harvard Medical School Boston, MA
Joseph A. Trapani
Cancer Immunology Program
Research Division
Peter MacCallum Cancer Centre
Victoria
Australia
CONTRIBUTORS |
xiii |
Peter Vandenabeele
Molecular Signaling and Cell Death Unit Department for Molecular Biomedical
Research VIB-Ghent University Ghent
Belgium
Ilia Voskoboinik
Cancer Immunology Program
Research Division
Peter MacCallum Cancer Centre
Victoria
Australia
Henning Walczak
Tumour Immunology Unit, Department
of Medicine
Imperial College London
London
United Kingdom
Christina Wang
Department of Medicine
Harbor-UCLA Medical Center
Los Angeles Biomedical Research Institute
David Geffen School of Medicine at UCLA
Torrance, CA
Nigel J. Waterhouse
Apoptosis and Cytotoxicity Laboratory
Mater Medical Research Institute
South Brisbane
Department of Medicine
University of Queensland
St. Lucia
Queensland
Australia
Kate Welsh
Apoptosis and Cell Death Research Program
Sanford-Burnham Medical Research Institute
La Jolla, CA
Yunfei Wen
Apoptosis and Cell Death Research Program
Sanford-Burnham Medical Research Institute
La Jolla, CA
Ding Xue
Department of MCD Biology
University of Colorado
Boulder, CO
Junying Yuan
Department of Cell Biology
Harvard Medical School
Boston, MA